ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAB1. A total of 13 filers reported holding ARRAY BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,740,000 | -87.0% | 9,000 | -92.5% | 0.02% | -90.2% |
| Q1 2019 | $21,101,000 | +45.3% | 120,000 | 0.0% | 0.19% | +52.8% |
| Q4 2018 | $14,527,000 | -4.3% | 120,000 | 0.0% | 0.13% | +13.4% |
| Q3 2018 | $15,175,000 | -5.9% | 120,000 | 0.0% | 0.11% | -22.8% |
| Q2 2018 | $16,121,000 | – | 120,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 20,075,000 | $25,225,000 | 0.77% |
| Redmile Group, LLC | 19,000,000 | $23,717,000 | 0.73% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 9,000,000 | $11,313,000 | 0.68% |
| CSS LLC/IL | 6,835,000 | $8,512,000 | 0.36% |
| Verition Fund Management LLC | 5,880,000 | $7,436,000 | 0.27% |
| Graham Capital Management, L.P. | 10,000,000 | $12,604,000 | 0.26% |
| SG Americas Securities, LLC | 120,000 | $15,175,000 | 0.11% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,000,000 | $6,235,000 | 0.07% |
| Nicholas Investment Partners, LP | 500,000 | $631,000 | 0.05% |
| DEUTSCHE BANK AG\ | 31,370,000 | $39,590,000 | 0.01% |